Xeris Biopharma Reports First Quarter 2026 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. ACN
3. IBM
4. MU
5. DPZ
6. NVDA
7. PRIM
8. META
9. SPY
10. SPCX

Go back to Xeris Biopharma Reports First Quarter 2026 Financial Results
(NASDAQ: XERS) Delayed: 7.19 +0.29 (4.20%)
Previous Close $6.90    52 Week High $ 
Open $6.90    52 Week Low $ 
Day High $7.24    P/E N/A 
Day Low $6.86    EPS $ 
Volume 286,045